Paul currently is Early Development Expert in the Alliance Management team of Janssen Benelux, and External Innovation Partnering Lead Benelux for Johnson & Johnson Innovation. He is involved in managing strategic partnerships with knowledge institutes and in scouting and assessing start-ups, spinouts and other innovation opportunities. Paul also acts as expert consultant and scientific coach to external research teams, biotech start-ups and entrepreneurs, mentoring and supporting them towards success.
Paul is a non-practicing pharmacist, PhD in clinical pharmacology and has more than 36 years’ experience in research and development of prescription and non-prescription pharmaceuticals, adjacent products and drug-device combination products, in academia (Leiden University) and in the pharmaceutical industry (Glaxo, Janssen/J&J).
Paul joined Janssen in 1994 and held various manager and functional leader roles in early clinical development, clinical pharmacology and medical affairs. For 15 years he was global head of clinical pharmacology at Janssen and responsible for the clinical pharmacology development and/or first approval of more than 20 NMEs and many line extensions in diverse therapeutic areas: oncology, infectious-, cardiovascular- and metabolic diseases, pain, neurology, psychiatry, gastroenterology and reproductive medicine.